|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Margaret D. Garikes |
Date | 10/19/2026 12:53:10 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 7148, Consolidated Appropriations Act, 2026, provisions related to APM bonus extension/incentive payments/qualifying provider revenue thresholds freeze
H.R. 4464 - Preventive Health Savings Act, all provisions
Matters related to State Maternal Mortality Review Committee's (MMRC)
Matters related to Women's health research funding/reproductive health/fertility treatments
Matters related to GME funding/teaching health centers
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Alexis |
Pierce |
|
|
|
Robert |
Redding |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R.1 - An act to provide for reconciliation pursuant to title II of H. Con. Res. 14 (PL 119-21), provisions related to student loans
H.R.2028 - REDI Act, all provisions
H.R.2314 - FAIR Act, all provisions
H.R.3890 - Resident Physician Shortage Reduction Act of 2025, all provisions
H.R.4681 - SPARC Act, all provisions
H.R.4731 - Resident Physician Shortage Reduction Act of 2025, all provisions
H.R.6468 - Rural Residency Planning and Development Act of 2025, all provisions
S.1380 - SPARC Act, all provisions
S.2439 - Resident Physician Shortage Reduction Act of 2025, all provisions
S.2715 - FAIR Act of 2025, all provisions
S.942 - REDI Act, all provisions
Comment Letter: [ED-2025-OPE-1042-0002] Accreditation, Innovation, and Modernization: Secretary's Recognition of Accrediting Agencies: Institutional Eligibility under the Higher Education Act, as Amended, Student Assistance General Provisions
Matters related to GME funding/teaching health centers
Matters related to the National Health Service Corps (NHSC)/loan repayment programs
Matters related to the National Resident Matching Program (MATCH) and foreign international medical graduates
Matters related to the NHSC Scholarship program
Matters related to Student Loans
Matters related to caps on GME
Matters related to J-1 visa sponsorship of international medical graduates
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of, Health & Human Services - Dept of (HHS), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Alexis |
Pierce |
|
|
|
Andrew |
Wankum |
|
|
|
Dana |
Lichtenberg |
|
|
|
Lindsey |
Brill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H. Res 1519 - Supporting the Designation of September 17, 2026 as National Physician Suicide Awareness Day to Raise Awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes.
H. Res. 1528 - Recognizing Suicide as a serious public health problem and expressing support for the designation of September 2026 as National Physician Suicide Prevention Month, as well as September 10, 2026 as World Suicide Prevention Day.
H.R. 1 - One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI), provisions related to changes in medicaid regarding "Release the Pressure" hypertension control campaign
H.R. 1254 - Rural Obstetrics Readiness Act, all provisions
H.R. 2314 - Fair Access In Residency (FAIR) Act, all provisions
H.R. 3492 - Protect Children's Innocence Act, all provisions
H.R. 9390 - Prices on the Wall Act, all provisions
H.R. 9395 - Transparency in Medicare Advantage Steering Act, all provisions
H.R. 9645 - Health Care Price Certainty for All Americans Act, all provisions
H.R. 9693 - The Patients First Act of 2026 - all provisions
H.R.10444 - The Stop Corporate Takeovers of Physicians Act, all provisions
H.R.1520 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions
H.R.2191 - Physician Led and Rural Access to Quality Care Act, all provisions
H.R.2332 - SHARE Act of 2025, all provisions
H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions
H.R.2850 - Youth Sports Facilities Act of 2025, all provisions
H.R.3022 - Restoring Rights of Physicians to Own Hospitals Act, all provisions
H.R.3164 - Ensuring Community Access to Pharmacist Services Act, all provisions
H.R.3170 - Improving Access to Workers Compensation for Injured Federal Workers Act of 2025, all provisions
H.R.4583 - Living Donor Protection Act of 2025, all provisions
H.R.4710 - No Surprises Act Enforcement Act, all provisions
H.R.5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions
H.R.5861 - Legacy Act of 2025, all provisions
H.R.628 - Honor Our Living Donors Act, all provisions
H.R.7023 - Affordable CHOICE Act, all provisions
H.R.7868 - Expanding Support for Living Donors Act of 2026, all provisions
H.R.7884 - Healthcare is Human Act of 2026, all provisions
H.R.8794 - FED UP with Bleeding Disorders Act of 2026, all provisions
H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions
H.R.929 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions
H.R.9393 - Lower Costs, More Transparency Act of 2026, all provisions
H.R.9396 - Prior Authorization Accountability Act, all provisions
S. 380 - Rural Obstetrics Readiness Act, all provisions
S.1390 - Physician Led and Rural Access to Quality Care Act, all provisions
S.1419 - Youth Sports Facilities Act of 2025, all provisions
S.1552 - Living Donor Protection Act of 2025, all provisions
S.1782 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions
S.2355 - Patients Deserve Price Tags Act, all provisions
S.2420 - No Surprises Act Enforcement Act, all provisions
S.2426 - Equitable Community Access to Pharmacist Services , all provisions
S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions
S.3097 - Health Information Privacy Reform Act, all provisions
S.3315 - Health Care Cybersecurity and Resiliency Act of 2026, all provisions
S.3599 - Affordable CHOICE Act, all provisions
S.3907 - Health Information Privacy Reform Act, all provisions
S.5419 - The Stop Corporate Takeovers of Physicians Act, all provisions
S.5496 - Health for the Commonwealth through Affordability Reform and Expansion Health Care (CARE) Act, all provisions
"Legitimate Medical Purpose" definition under the Controlled Substance Act
"Still at Risk" wristband initiative
Jeanette Acosta Invest in Women's Health Act
Comment Letter: [ACF-2026-0595] Reducing Federal Burden for Head Start Programs
Comment Letter: [CMS-2026-1255-0001] Medicare and Medicaid Programs: Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, etc.
Comment Letter: [REG-118484-25; CMS-9879-P; RIN 0938-AV94; RIN 1210-AC40; RIN 1545-BS02] Excepted Fertility Benefits
Comment Letter: Request for Information (RFI) on Health Coverage that Works for Everyone
Comment Letter: [2120-AM18] Improving Emergency Medical Kit Efficacy and Flexibility in Commercial Airline Operations
Draft: Health Infrastructure Security and Accountability Act
Draft: Noncompete clauses in physician contracts
Matters related to AI use in prior authorization
Matters related to Alternative Payment Model bonuses/incentive payments and freezing the qualifying provider revenue thresholds
Matters related to Data privacy, cybersecurity, and AI
Matters related to Health care consolidation
Matters related to the Health Insurance Portability and Accountability Act (HIPAA) and electronic records
Matters related to Maternal health and hypertensive disorder during pregnancy
Matters related to Medical devices
Matters related to Nutrition
Matters related to the Office of the National Coordinator for Health Information Technology (ONC) improving electronic health record certification; implementation of 21st Century Cures Act provisions; digital health policies, and reduction of technology burden on physicians entering into the Quality Payment Program
Matters related to Payment for AI services within health care
Matters related to the Public Health effects of opioid medications
Matters related to Unbundling of Maternity Care of Current Procedural Terminology (CPT) Codes
Matters related to the United States Preventive Services Task Force (USPSTF)
Matters related to Vaccines/ACIP
Matters related to ACA benefits and payments
Matters related to high-resolution anoscopy services
Matters related to peptides
Matters related to physician prescribing of antibiotics
Matters related to reproductive health
Matters related to the Authorization of ENDS Products Age Verification
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Administration for Children & Families (ACF), Food & Drug Administration (FDA), Defense - Dept of (DOD), Treasury - Dept of, Labor - Dept of (DOL), Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Robert |
Redding |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
Angela |
Franklin |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Matthew |
Reid |
|
|
|
Ashley |
Delosh |
|
|
|
Philip |
Lynch |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
|
Shannon |
Curtis |
|
|
|
Bryan |
Hull |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Sierra |
Burgon |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Matthew |
Reid |
|
|
|
Ashley |
Delosh |
|
|
|
Philip |
Lynch |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
|
Shannon |
Curtis |
|
|
|
Bryan |
Hull |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Sierra |
Burgon |
|
|
|
Shawn |
Brooks |
|
|
|
Koryn |
Rubin |
|
|
|
Rachel |
Hollander |
|
|
|
Neda |
Ashtari |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 1521 - The DOC Access Act, all provisions
H.R.1201 - Doctors in our Borders Act, all provisions
H.R.1585 - Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R.5283 - Healthcare Workforce Resilience Act, all provisions
H.R.7961 - H-1Bs for Physicians and the Healthcare Workforce Act, all provisions
S.2650 - DOCTORS Act, all provisions
S.2759 - Healthcare Workforce Resilience Act, all provisions
S.4637 - Conrad 30 Physician Workforce Optimization Act, all provisions
S.709 - Conrad State 30 and Physician Access Reauthorization Act, all provisions
Comment Letter: [USCIS-2026-0298] Fee for Certain H-1B Petitions
Alternative pathways to citizenship for foreign international medical graduates
Matters related to filing fees for physician H-1B visa holders
Matters related to J-1 visa processing for physicians
Matters related to Proclamation 10998/Physician exemption
Matters related to regulatory changes to duration of status for J-1 physicians.
Matters related to exempting physicians from new H1-B visa fees
Regulatory changes to processing physician H-1B visas including processing visas for physicians from presidentially banned countries
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), State - Dept of (DOS), Health Resources & Services Administration (HRSA), U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Robert |
Redding |
|
|
|
Christopher |
Sherin |
|
|
|
Alexis |
Pierce |
|
|
|
Dana |
Lichtenberg |
|
|
|
Angela |
Franklin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
S.632 - IHS Workforce Parity Act of 2025, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4093 - Apples to Apples Comparison Act of 2025, all provisions
H.R. 483 - Health Care Efficiency Through Flexibility Act, all provisions
H.R. 6728 - Linking Seniors to Needed Legal Services Act of 2025, all provisions
H.R. 9393 - Lower Costs, More Transparency Act, all provisions
H.R. 9397 - Premium Transparency Act, all provisions
H.R. 9468 - Saving Today's Ascute-Care Resouces (STAR) act, all provisions
H.R. 9693 - The Patients First Act of 2026 - all provisions
H.R.1 - An act to provide for reconciliation pursuant to title II of H. Con. Res. 14 (PL 119-21), provisions related to Medicare payment reform, Medicaid reforms, Alternative Payment Models (APMs)
H.R.1317 - I CAN Act, all provisions
H.R.1614 - To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program, all provisions
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10)
H.R.2120 - ROCR Value Based Program Act, all provisions
H.R.2433 - Reducing Medically Unnecessary Delays in Care Act of 2025, all provisions
H.R.2757 - Medicare Audiology Access Improvement Act of 2025, all provisions
H.R.2902 - SOAR Act of 2025, all provisions
H.R.3069 - Medicare for All Act, all provisions
H.R.3108 - RPM Access Act, all provisions, all provisions
H.R.3514 - Improving Seniors Timely Access to Care Act of 2025, all provisions
H.R.3878 - RNs for Rural Health Act of 2025, all provisions
H.R.4002 - Patient Access to Higher Quality Health Care Act of 2025, all provisions
H.R.4206 - CONNECT for Health Act of 2025, all provisions
H.R.483 - Health Care Efficiency Through Flexibility Act, all provisions
H.R.4977 - Connected MOM Act, all provisions
H.R.5081 - Telehealth Modernization Act, all provisions
H.R.5178 - Sickle Cell Disease Comprehensive Care Act, all provisions
H.R.5243 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
H.R.5347 - Health Care Efficiency Through Flexibility Act, all provisions
H.R.539 - Chiropractic Medicare Coverage Modernization Act of 2025, all provisions
H.R.5467 - PAAT Act, all provisions
H.R.5940 - Seniors Deserve SMARTER Care Act of 2025, all provisions
H.R.6160 - Strengthening Medicare for Patients and Providers Act, all provisions
H.R.6280 - Access to Genetic Counselor Services Act of 2025, all provisions
H.R.7520 - Efficiency Adjustment Delay Act, all provisions
H.R.786 - Preserving Patient Access to Accountable Care Act, all provisions
H.R.7905 - Diabetes Foot Health Access and Modernization Act of 2026, all provisions
H.R.8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program, all provisions
H.R.8163 - Provider Reimbursement Stability Act of 2026, all provisions
H.R.8261 - Chronic Care Management Improvement Act of 2026, all provisions
H.R.8375 - Medicare Advantage Improvement Act of 2026, all provisions
H.R.8500 - Timely Access to Coverage Decisions Act of 2026, all provisions
H.R.8622 - Medicare Physician Data-driven Performance Payment System Act of 2026, all provisions
H.R.879 - Medicare Patient Access and Practice Stabilization Act of 2025, all provisions
H.R.9392 - Medicare Advantage Cost Transparency Act, all provisions
H.R.9644 - Medicare Advantage MLR Transparency Act, all provisions
S.1031 - ROCR Value Based Program Act, all provisions
S.106 - Chiropractic Medicare Coverage Modernization Act of 2025, all provisions
S.1105 - No UPCODE Act, all provisions
S.1261 - CONNECT for Health Act of 2025, all provisions
S.1399 - Health Tech Investment Act, all provisions
S.141 - Connected MOM Act, all provisions
S.1460 - Preserving Patient Access to Accountable Care Act, all provisions
S.1535 - Rural Patient Monitoring (RPM) Access Act, all provisions
S.1640 - Medicare Patient Access and Practice Stabilization Act of 2025, all provisions
S.1816 - Improving Seniors Timely Access to Care Act of 2025, all provisions
S.1996 - Medicare Audiology Access Improvement Act of 2025, all provisions
S.2709 - Telehealth Modernization Act, all provisions
S.3480 - Seniors Deserve SMARTER Care Act of 2025, all provisions
S.3607 - Access to Genetic Counselor Services Act of 2026, all provisions
S.5168 - Provider Reimbursement Stability Act of 2026, all provisions
S.5180 - Provider Reimbursement Stability Act, all provisions
S.665 - Fatal Overdose Reduction Act of 2025, all provisions
S.721 - Sickle Cell Disease Comprehensive Care Act, all provisions
S.891 - Bipartisan Health Care Act, all provisions
Comment Letter: [CMS 0057 F] 2024 CMS Interoperability and Prior Authorization final rule
Comment Letter: [CMS-0062-P] Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
Comment Letter: [CMS-1844-P] CY 2027 Home Health Prospective Payment System proposed rule
Comment Letter: [CMS-1848-P] Medicare Physician Fee Schedule, including conversion factors, Modifier -25 payment reduction, efficiency adjustment, RPM/RTM, Maternity Care Services codes, CPT request for information, MIPS/MVP transition, Medicare Shared Savings Program, and Qualifying APM Participant determinations
Comment Letter: [CMS-1850-P] Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Comment Letter: [CMS-2452-P] Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes
Comment Letter: [CMS-2454-IFC] Medicaid Program; Community Engagement Requirement for Certain Individuals
Comment Letter: [CMS-3847-NC] Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway
Comment Letter: [CMS-9874-NC] Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard
Comment Letter: [HHS-OS-2026-0332] Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making
Comment Letter: Request for Information (RFI) Strengthening the Medicare Physician Payment System
Statement for the Record: Examining Legislative Proposals to Reform Medicare Provider Payment and Bolster Health Care Cybersecurity
Medicare program: ACO (Accountable Care Organization) REACH Model
Medicare program: ACO/APM flexibilities
Medicare program: Advanced APM reporting
Medicare program: AI chatbots/Medicare Advantage preventive screens
Medicare program: AI services/payment
Medicare program: Aligned Networks and interoperability
Medicare program: Alternative Payment Models (APMs)
Medicare program: Certified electronic health record and PI
Medicare program: Coding
Medicare program: Data privacy/cybersecurity
Medicare program: Data-Driven Performance Payment System
Medicare program: Digital quality measures
Medicare program: G2211 Inherent Complexity Code
Medicare program: Health Information Technology/physician burdens
Medicare program: Indirect practice expense
Medicare program: Informed decision-making among beneficiaries
Medicare program: Medicare Advantage provider networks/physician experience
Medicare program: Medicare Diabetes Prevention Program
Medicare program: Medicare Economic Index (MEI)/inflationary updates
Medicare program: Medicare Part D issues
Medicare program: Medicare physician payment/budget neutrality
Medicare program: Merit-based Incentive Payment System (MIPS)/reforms and penalties
Medicare program: MIPS Promoting Interoperability
Medicare program: MIPS quality and cost measures
Medicare program: MIPS Value Pathways (MVPs) reform
Medicare program: Organ transplantation access
Medicare program: Prior authorization/Medical billing transition
Medicare program: Promoting Interoperability (PI) Program
Medicare program: Provider directories
Medicare program: Public Health Reporting and Data Exchange
Medicare program: Quality Payment Program
Medicare program: Review Choice Demonstration (RCD)/Inpatient Rehabilitation Facility (IRF)
Medicare program: RVS Update Committee (RUC) and Current Procedural Terminology (CPT) issues
Medicare program: Shared Savings Program
Medicare program: Site Neutral Payment
Medicare program: Traditional Medicare/Medicare Advantage enrollment difficulties
Medicare program: Wasteful and Inappropriate Service Reduction (WISeR) and Ambulatory Specialty Model
Medicaid program: Changes in Children's Health Insurance Program (CHIP) and Affordable Care Act insurance marketplaces
Medicaid program: Community engagement/medical frailty exemption
Medicaid program: Practice of Medicine
Medicaid program: State directed payments
Medicaid program: Work requirements, per capita caps, provider taxes, Federal Medical Assistance Percentage (FMAP) changes
Medicare and Medicaid programs: ACO REACH (Realizing Equity, Access, and Community Health) Model Reform
Medicare and Medicaid programs: Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model reform.
Medicare and Medicaid programs: Center for Medicare and Medicaid Innovation (CMMI) reforms
Medicare and Medicaid programs: CMMI reform/Physician AI use
Medicare and Medicaid programs: Evaluation and Management (E/M) codes
Medicare and Medicaid programs: High-cost disposable supplies/billing codes Medicare and Medicaid programs: Indirect Practice Expense Relative Value Updates (RVU) changes
Medicare and Medicaid programs: Interoperability
Medicare and Medicaid programs: LEAD (Long-term Enhanced ACO Design) Model Reform
Medicare and Medicaid programs: MACRA/physician burdens
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/broad reform
Medicare and Medicaid programs: Prior authorization
Medicare and Medicaid programs: TEAM (Transforming Episode Accountability Model) changes
Medicare and Medicaid programs: Telehealth and Digital Health
Draft: Artificial intelligence in prior authorization denials by Medicare Advantage organizations
Draft: GOLD CARD Act
Draft: MACRA/MIPS program reform
Draft: Transparency in Downcoding Model Act
Draft: Value in Health Care Act
Matters related to downcoding by Insurace plans
Matters related to drug price negotiations
Matters related to expiring Medicare Physician payment rates
Matters related to Modifier-25/Multiple Procedure Payment Reductions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), Medicare Payment Advisory Commission (MedPAC), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Robert |
Redding |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
Angela |
Franklin |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Bryan |
Hull |
|
|
|
Philip |
Lynch |
|
|
|
Shannon |
Curtis |
|
|
|
Alexis |
Pierce |
|
|
|
Ashley |
Delosh |
|
|
|
Neda |
Ashtari |
|
|
|
Shawn |
Brooks |
|
|
|
Rachel |
Hollander |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
S.1767 - Physician and Patient Safety Act, all provisions
S.232 - Preventing Algorithmic Collusion Act of 2025, all provisions
Matters related to independent dispute resolution processes
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Lisa |
Myers |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Robert |
Redding |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R.2234 - Ensuring Veterans Timely Access to Anesthesia Care Act of 2025, all provisions
H.R.4837 - Written Informed Consent Act, all provisions
H.R.9237 - Take Care of Americas Veterans Act, all provisions
H.R.9862 - Responsible Artificial Intelligence for Veterans Act
Comment Letter: [VA-2026-VACO-0001] Veterans Health Administration System of records Notice, protection and sharing of veterans' health records
Matters related to records of notice for patient medical records
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
|
Angela |
Franklin |
|
|
|
Alexis |
Pierce |
|
|
|
Matthew |
Reid |
|
|
|
Lisa |
Myers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R.1189 - National Plan for Epilepsy Act
H.R.2767 - BRAIN Act, all provisions
S.1330 - BRAIN Act, all provisions
S.494 - National Plan for Epilepsy Act
Comment Letter: [OMB-2026-0034] Regulation for Federal Financial Assistance
Matters related to National Institutes of Health (NIH) funding and research
Matters related to measuring and rewarding scientific impact
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Angela |
Franklin |
|
|
|
Alexis |
Pierce |
|
|
|
Ashley |
Delosh |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Philip |
Lynch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S. 3014 - Ensuring Timely Access to Generics Act
S.3822 - Break Up Big Medicine Act, all provisions
S.526 - Pharmacy Benefit Manager Transparency Act of 2025, all provisions
S.527 - Prescription Pricing for the People Act of 2025, all provisions
Matters related to Drug Shortages
Matters related to Competition and Transparency of Prescription Drugs
Matters related to commonsense policy option to lower drug prices for patients
Matters related to competition and transparency in the prescription supply chain
Matters related to Pharmacy Benefit Managers
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Katherine |
Dapper |
|
|
|
Ashley |
Delosh |
|
|
|
Angela |
Franklin |
|
|
|
Christopher |
Sherin |
|
|
|
Margaret |
Garikes |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
H.R. 9734 - Protecting Patients from automated Denials Act
H.R.2794 - NO FAKES Act of 2025, all provisions
H.R.8031 - GUARDRAILS Act, all provisions
H.R.8413 - SECURE Data Act, all provisions
H.R.8915 - NO FAKES Act of 2026, all provisions
S.1367 - NO FAKES Act of 2025, all provisions
S.4591 - NO FAKES Act of 2026, all provisions
S.4916 - Aging with Artificial Intelligence Act of 2026, all provisions
Protect Kids from Human-Like Chatbots Act
U.S. Food and Drug Administration digital health regulation
Draft: Generative AI Discussion Paper
Draft: The Republic Unifying Meritocratic Performance Advancing Machine intelligence by Eliminating Regulatory Interstate Chaos Across American Industry Act (TRUMP AMERICA AI Act)
Matters related to digital health and AI
Matters related to AI oversight
Matters related to Cybersecurity
Matters related to Digital health and the autonomous practice of medicine
Matters related to Electronic delivery of required health plan documents to plan beneficiaries
Matters related to Mental Health Chatbots/AI Chatbots
Matters related to Prohibiting Physician Deep Fakes
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Lisa |
Myers |
|
|
|
Ashley |
Delosh |
|
|
|
Christopher |
Sherin |
|
|
|
Katherine |
Dapper |
|
|
|
Jeffery |
Coughlin |
|
|
|
Lindsey |
Brill |
|
|
|
Matthew |
Reid |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code WEL
16. Specific lobbying issues
H.R.9058 - Residential AED and CPR Preparedness Act of 2026, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Sherin |
|
|
|
Todd |
Askew |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Comment Letter: [2026-11602] HHS Request for Comment on Chronic Disease of Addiction
Matters related to the Chronic Disease of Addiction
Matters related to substance use and mental health
Matters related to fentanyl
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Myers |
|
|
|
Sandy |
Marks |
|
|
|
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 9504 - Tax Exempt Hospital Transparency Act
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Marino |
|
|
|
Lisa |
Myers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |